Liver allograft fibrosis and minimization of immunosuppression

Pediatric transplantation

Volumn 19, Issue 7, 2015, Pages 667-668

  Ranganathan, Sarangarajan ^a   Celik, Neslihan ^b   Mazariegos, George ^b   Sindhi, Rakesh ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ACUTE GRAFT REJECTION; ALLOIMMUNITY; BIOCOMPATIBILITY; DISEASE CLASSIFICATION; DRUG DOSE REDUCTION; EDITORIAL; FEMALE; GRAFT REJECTION; HEPATITIS; HLA MATCHING; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; LIVER ALLOGRAFT; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; MORPHOMETRICS; RISK FACTOR; SENSITIZATION;

CALCINEURIN INHIBITORS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE;

EID: 85027933596     PISSN: None     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12590     Document Type: Editorial

References (7)